Quinazoline derivatives as VEGF inhibitors
    9.
    发明授权
    Quinazoline derivatives as VEGF inhibitors 有权
    喹唑啉衍生物作为VEGF抑制剂

    公开(公告)号:US08642608B2

    公开(公告)日:2014-02-04

    申请号:US12761105

    申请日:2010-04-15

    CPC分类号: C07D401/12

    摘要: The invention relates to quinazoline derivatives of formula (I), wherein m is an integer from 1 to 3; R1 represents halogeno or C1-3alkyl; X1 represents —O—; R2 is selected from one of the following three groups: 1) C1-5alkylR3 (wherein R3 is piperidinyl-4-yl which may bear one or two substituents selected from hydroxy, halogeno, C1-4alkyl, C1-4hydroxyalkyl and C1-4alkoxy; 2) C2-5alkenylR3 (wherein R3 is as defined hereinbefore); 3) C2-5alkynylR3 (wherein R3 is as defined hereinbefore); and wherein any alkyl, alkenyl or alkynyl group may bear one or more substituents selected from hydroxy, halogeno and amino; and salts thereof; processes for their preparation, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.

    摘要翻译: 本发明涉及式(I)的喹唑啉衍生物,其中m为1至3的整数; R1代表卤代或C1-3烷基; X1表示-O-; R2选自以下三个基团之一:1)C 1-5烷基R 3(其中R 3是可以带有一个或两个选自羟基,卤代C 1-4烷基,C 1-4羟烷基和C 1-4烷氧基的取代基的哌啶-4-基; 2)C 2-5烯基R 3(其中R 3如上所定义); 3)C 2-5炔基R 3(其中R 3如上文所定义); 并且其中任何烷基,烯基或炔基可以具有一个或多个选自羟基,卤代和氨基的取代基; 及其盐; 其制备方法,含有式(I)化合物或其药学上可接受的盐作为活性成分的药物组合物。 式(I)化合物及其药学上可接受的盐抑制VEGF的作用,其在治疗许多疾病状态(包括癌症和类风湿性关节炎)中是有价值的。